US Stock MarketDetailed Quotes
VNDA Vanda Pharmaceuticals
- 4.620
- +0.140+3.13%
Close Apr 26 16:00 ET
- 4.520
- -0.100-2.17%
Post 17:46 ET
265.82MMarket Cap115.50P/E (TTM)
4.625High4.450Low821.94KVolume4.500Open4.480Pre Close3.76MTurnover1.58%Turnover Ratio115.50P/E (Static)57.54MShares7.00052wk High0.49P/B240.45MFloat Cap3.29552wk Low--Dividend TTM52.05MShs Float33.440Historical High--Div YieldTTM3.91%Amplitude0.450Historical Low4.577Avg Price1Lot Size
About Vanda Pharmaceuticals Company
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
Company Profile
SymbolVNDA
Company NameVanda Pharmaceuticals
Listing DateApr 12, 2006
Issue Price10.00
Founded2002
CEODr. Mihael Hristos Polymeropoulos,M.D.
MarketNASDAQ
Employees203
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2200 Pennsylvania Avenue NW,Suite 300E
CityWashington
ProvinceDistrict of Columbia
CountryUnited States of America
Zip Code20037
Phone1-202-734-3400
Websitehttp://www.vandapharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Mihael Hristos Polymeropoulos,M.D.
- Chairman of the Board, President and Chief Executive Officer
- 4.27M
- Joakim Wijkstrom
- Senior Vice President and Chief Marketing Officer
- 1.62M
- Kevin Moran
- Senior Vice President, Principal Accounting Officer, Chief Financial Officer and Treasurer
- 1.44M
- Gunther Birznieks
- Senior Vice President, Business Development
- 1.47M
- Timothy Williams
- Senior Vice President, General Counsel and Secretary
- 1.50M
- Stephen Ray Mitchell
- Independent Director
- 279.99K
- Phaedra Chrousos
- Independent Director
- 294.06K
- Tage Honore
- Independent Director
- --
- Richard W. Dugan
- Lead Independent Director
- 317.08K
- Anne Sempowski Ward
- Independent Director
- 296.24K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg